MetaverseNCT07516041
Metaverse- and VR-Supported Education in a Digital Breastfeeding Museum: Long-Term Effects on Breastfeeding Process, Self-Efficacy, and Motivation
A study testing Training Supported by Metaverse and Virtual Reality (VR) in the Digital Breastfeeding Museum Group and Virtual Reality Headset (Meta Quest 2) in people with Metaverse and Virtual Reality, run by Uludag University at 1 site in Turkey (Türkiye).
Trial summary
This randomized controlled prospective study aimed to evaluate the long-term effects of Metaverse- and virtual reality (VR)-supported education provided in a digital breastfeeding museum on the breastfeeding process, breastfeeding self-efficacy, breastfeeding motivation, and breastfeeding-related problems in… Read more about this study
- Who is it for?
- Ages 18 years and older, women onlyHealthy volunteers can take part
- Conditions the study is for
- Metaverse, Virtual Reality, Digital Museum
- What is being tested?
- Training Supported by Metaverse and Virtual Reality (VR) in the Digital Breastfeeding Museum Group and Virtual Reality Headset (Meta Quest 2)
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 40 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 15 Mar 2024to 27 Mar 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- Women only
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Having previously participated in a randomized controlled trial by providing written informed consent,
- Primiparous mothers who voluntarily agree to participate in the new study,
- Being reachable by telephone and having digital access to complete an online questionnaire,
- Being able to read and understand Turkish,
- Having sufficient cognitive ability to recall the breastfeeding process,
- The infant not having any health condition requiring prolonged hospitalization in a neonatal intensive care unit.
Who cannot join
- The presence of a serious health condition in the mother or infant that may contraindicate breastfeeding,
- Having experienced infant loss during the postpartum period,
- A diagnosis of a severe psychiatric or physiological condition in the mother during the postpartum period that may interfere with breastfeeding.
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
Fenerbahçe Üniversitesi
Ataşehir, Istanbul, 34758
About this study
Official title: The Long-Term Effects of Metaverse- and Virtual Reality-Supported Education Delivered to Mothers in a Digital Breastfeeding Museum on the Breastfeeding Process, Self-Efficacy, and Motivation: A Prospective Randomized Controlled Study
This randomized controlled prospective study aimed to evaluate the long-term effects of Metaverse- and virtual reality (VR)-supported education provided in a digital breastfeeding museum on the breastfeeding process, breastfeeding self-efficacy, breastfeeding motivation, and breastfeeding-related problems in primiparous mothers. While the intervention group received Metaverse- and VR-supported breastfeeding education in the digital breastfeeding museum, the control group received standard education provided in routine antenatal classes. The study population consisted of primiparous mothers who had participated in the previous randomized controlled study and voluntarily agreed to take part in this new prospective study. Participants were followed at four postpartum periods: 0-6 months, 6-12 months, 12-18 months, and 18-24 months. Data were collected using the Breastfeeding Self-Efficacy Scale-Short Form (BSES-SF), the Breastfeeding Motivation Scale, the Breastfeeding Problems Assessment Scale, and a questionnaire form (including breastfeeding duration and other parameters). Assessments were conducted at the planned follow-up intervals.
Read the detailed description
Breastfeeding is the most ideal method for ensuring infants' healthy growth and nutrition and is a public health priority due to its short- and long-term health benefits. Emerging technologies in the 21st century have added new dimensions to educational processes, and tools such as virtual reality (VR) and the Metaverse support traditional educational methods by offering multimodal learning opportunities. The literature indicates that the use of VR in breastfeeding education is limited, and no Metaverse-based studies have been reported.
This study represents a prospective follow-up of a randomized controlled trial conducted between July 2023 and April 2024 in three hospitals. In the previous study, 53 primiparous pregnant women-who were attending antenatal classes for the first time in their third trimester and had no prior breastfeeding experience-were randomly assigned to an intervention group (n=28) and a control group (n=25). In the new prospective study, 20 mothers from each group were reached, resulting in a total of 40 participants who continued to be followed in their originally assigned groups.
Participants in the intervention group received Metaverse- and VR-supported breastfeeding education in a digital breastfeeding museum consisting of multiple educational rooms. They explored the museum through personalized avatars using VR headsets, accessing educational content that included photo frames, written boards, and instructional videos. The control group continued to receive routine antenatal breastfeeding education at the participating hospitals. In the prospective follow-up, no additional postnatal interventions were applied; data were collected only on long-term outcomes at four postnatal periods: 0-6 months, 6-12 months, 12-18 months, and 18-24 months. Data collection tools included maternal and infant demographic forms, a breastfeeding knowledge questionnaire, the Breastfeeding Motivation Scale, the Breastfeeding Self-Efficacy Scale-Short Form, and the Breastfeeding Problems Assessment Scale. Participants were contacted by phone, and data were collected via online surveys.
This study is the first to prospectively evaluate the long-term effects of Metaverse- and VR-supported digital breastfeeding education on postnatal breastfeeding practices, self-efficacy, and motivation. It provides evidence on the sustained impact of technology-based educational models on breastfeeding behavior.
- Conditions
- Metaverse, Virtual Reality, Digital Museum, Breastfeeding Education, Breastfeeding Self-Efficacy, Breastfeeding Duration
- Being tested
- Training Supported by Metaverse and Virtual Reality (VR) in the Digital Breastfeeding Museum Group, Virtual Reality Headset (Meta Quest 2)
- Keywords
- Breastfeeding Education,Breastfeeding Self-Efficacy, Breastfeeding Motivation,Breastfeeding Process
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Training Supported by Metaverse and Virtual Reality (VR) in the Digital Breastfeeding Museum GroupOther
In the previous randomized controlled study, pregnant women in this group received Metaverse- and virtual reality (VR)-supported education in a digital breastfeeding museum. The sole intervention consisted of a digital breastfeeding education program delivered via virtual reality and Metaverse platforms. All content was provided exclusively through head-mounted VR devices, without the need for any pharmacological agents or invasive procedures. The environment was explored by participants using virtual reality (VR) headsets (Meta Quest 2).
In the prospective follow-up study, no additional postnatal education was provided; only long-term follow-up data were collected at four postpartum periods: 0-6 months, 6-12 months, 12-18 months, and 18-24 months.
Virtual Reality Headset (Meta Quest 2)Device
A head-mounted virtual reality (VR) device used to deliver immersive educational content in a digital breastfeeding museum. Participants interacted with the virtual environment using VR headsets.
| Study group | Role | What they receive |
|---|---|---|
| Routine Antenatal Class Education Program Group | No intervention | In the previous randomized controlled study, no additional intervention was administered to the pregnant women in this group; they only received the routine breastfeeding education provided by the antenatal education program. In the prospective follow-up study, no additional postnatal education was provided; only long-term follow-up data were collected at four postpartum periods: 0-6 months, 6-12 months, 12-18 months, and 18-24 months. |
| Training Supported by Metaverse and VR in the Digital Breastfeeding Museum Group | Experimental | In the previous randomized controlled study, pregnant women in this group received Metaverse- and virtual reality (VR)-supported education in a digital breastfeeding museum. The sole intervention consisted of a digital breastfeeding education program delivered via virtual reality and Metaverse platforms. All content was provided exclusively through head-mounted VR devices, without the need for any pharmacological agents or invasive procedures. The environment was explored by participants using virtual reality (VR) headsets (Meta Quest 2).
In the prospective follow-up study, no additional postnatal education was provided; only long-term follow-up data were collected at four postpartum periods: 0-6 months, 6-12 months, 12-18 months, and 18-24 months. Receives: Other: Training Supported by Metaverse and Virtual Reality (VR) in the Digital Breastfeeding Museum Group; Device: Virtual Reality Headset (Meta Quest 2) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Breastfeeding Motivation Scale
The Breastfeeding Motivation Scale was developed by Kestler-Peleg and colleagues in 2015. It is a 24-item, five-point Likert-type scale with five subscales. Cronbach's alpha coefficients for the subscales range from 0.56 to 0.89. The validity and reliability of the scale for the Turkish population were tested by Mızrak in 2017 among primiparous and multiparous women.The Turkish version of the Breastfeeding Motivation Scale for primiparous women consists of 23 items, five subscales, and uses a four-point Likert format. The subscales are: (1) integrated regulation, (2) intrinsic motivation - identified regulation, (3) introjected regulation - social approval, (4) introjected regulation - social pressure, and (5) external regulation - instrumental needs. The scale does not have a total score; subscale scores are evaluated individually. A higher score on a subscale indicates greater motivation in the domain represented by that subscale.
Measured: Assessed during ongoing breastfeeding up to 24 months postpartum.
Breastfeeding Self-Efficacy Scale - Short Form (BSES-SF) Score
The Breastfeeding Self-Efficacy Scale is used to assess how confident mothers feel about their ability to breastfeed. The original scale was developed in 1999. In 2003, the scale was shortened to a 14-item version known as the Breastfeeding Self-Efficacy Scale - Short Form (BSES-SF), which is recommended for use in research and practice. The BSES-SF is a 5-point Likert-type scale, with responses ranging from 1 ("Not at all confident") to 5 ("Always confident"). The minimum possible score is 14, and the maximum is 70. Higher scores indicate higher levels of breastfeeding self-efficacy. The Turkish validity and reliability study of the scale was conducted in 2010. In this study, the Cronbach's alpha coefficient was reported as 0.86.
Measured: 0-6 months, 6-12 months, 12-18 months, and 18-24 months postpartum
Breastfeeding Problems Assessment Scale
The Breastfeeding Problems Assessment Scale was developed by Karen Wambach in 1990. The validity and reliability of the Turkish version were established by Uyanık in 2019, with a Cronbach's alpha of 0.776. Turkish form consists only of the first section, containing 18 items across five subscales: mechanical concerns, process concerns, insufficient milk concerns, nipple concerns, and social concerns. Items are scored as follows: 1 = none, 2 = mild, 3 = moderate, 4 = severe, 5 = unbearable. Total scores range from 18 to 90, with higher scores indicating more severe breastfeeding problems. The scale has been reported as a valid tool for the Turkish population. In the present study, Cronbach's alpha was found to be 0.83.
Measured: 0-6 months, 6-12 months, 12-18 months, and 18-24 months postpartum
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted7 Apr 2026
- Study start15 Mar 2024
- Primary completion27 Mar 2026
- Study completion27 Mar 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for MetaverseStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- The study was designed as a prospective randomized controlled trial consisting of two parallel groups: an intervention group receiving Metaverse- and VR-supported education in the digital breastfeeding museum, and a control group receiving standard antenatal class education.
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 40 participants (actual)
Sponsor and investigators
- Lead sponsor
- Uludag University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Aysenur Akkaya Gul, Fenerbahce University
- Investigators
- Assistant Professor Ayşenur AKKAYA GÜL, PhD, Principal investigator, Fenerbahce University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07516041
- Sponsor's protocol ID
- UU-26-DIGI-BF-MUSE/AAKKAYAGUL
- Status last verified
- Apr 2026
- First submitted
- 27 Mar 2026
- Last updated
- 7 Apr 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: De-identified individual participant data (IPD) may be shared upon reasonable request.
Study at a glance
From the registry record, last updated by the sponsor on 7 Apr 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Long-Term Effects of Metaverse- and Virtual Reality-Supported Education Delivered to Mothers in a Digital Breastfeeding Museum on the Breastfeeding Process, Self-Efficacy, and Motivation: A Prospective Randomized Controlled Study
- ClinicalTrials.gov ID
- NCT07516041
- Acronym / sponsor ID
- UU-26-DIGI-BF-MUSE/AAKKAYAGUL
- Conditions
- Metaverse, Virtual Reality, Digital Museum, Breastfeeding Education, Breastfeeding Self-Efficacy, Breastfeeding Duration
- Keywords
- Breastfeeding Education,Breastfeeding Self-Efficacy, Breastfeeding Motivation,Breastfeeding Process
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 40 participants (actual)
- Lead sponsor
- Uludag UniversityUniversity, hospital or other
- Study start
- 15 Mar 2024 (actual)
- Primary completion
- 27 Mar 2026 (actual)
- Study completion
- 27 Mar 2026 (actual)
- First posted
- 7 Apr 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This randomized controlled prospective study aimed to evaluate the long-term effects of Metaverse- and virtual reality (VR)-supported education provided in a digital breastfeeding museum on the breastfeeding process, breastfeeding self-efficacy, breastfeeding motivation, and breastfeeding-related problems in primiparous mothers. While the intervention group received Metaverse- and VR-supported breastfeeding education in the digital breastfeeding museum, the control group received standard education provided in routine antenatal classes. The study population consisted of primiparous mothers who had participated in the previous randomized controlled study and voluntarily agreed to take part in this new prospective study. Participants were followed at four postpartum periods: 0-6 months, 6-12 months, 12-18 months, and 18-24 months. Data were collected using the Breastfeeding Self-Efficacy Scale-Short Form (BSES-SF), the Breastfeeding Motivation Scale, the Breastfeeding Problems Assessment Scale, and a questionnaire form (including breastfeeding duration and other parameters). Assessments were conducted at the planned follow-up intervals.
Detailed description
Breastfeeding is the most ideal method for ensuring infants' healthy growth and nutrition and is a public health priority due to its short- and long-term health benefits. Emerging technologies in the 21st century have added new dimensions to educational processes, and tools such as virtual reality (VR) and the Metaverse support traditional educational methods by offering multimodal learning opportunities. The literature indicates that the use of VR in breastfeeding education is limited, and no Metaverse-based studies have been reported.
This study represents a prospective follow-up of a randomized controlled trial conducted between July 2023 and April 2024 in three hospitals. In the previous study, 53 primiparous pregnant women-who were attending antenatal classes for the first time in their third trimester and had no prior breastfeeding experience-were randomly assigned to an intervention group (n=28) and a control group (n=25). In the new prospective study, 20 mothers from each group were reached, resulting in a total of 40 participants who continued to be followed in their originally assigned groups.
Participants in the intervention group received Metaverse- and VR-supported breastfeeding education in a digital breastfeeding museum consisting of multiple educational rooms. They explored the museum through personalized avatars using VR headsets, accessing educational content that included photo frames, written boards, and instructional videos. The control group continued to receive routine antenatal breastfeeding education at the participating hospitals. In the prospective follow-up, no additional postnatal interventions were applied; data were collected only on long-term outcomes at four postnatal periods: 0-6 months, 6-12 months, 12-18 months, and 18-24 months. Data collection tools included maternal and infant demographic forms, a breastfeeding knowledge questionnaire, the Breastfeeding Motivation Scale, the Breastfeeding Self-Efficacy Scale-Short Form, and the Breastfeeding Problems Assessment Scale. Participants were contacted by phone, and data were collected via online surveys.
This study is the first to prospectively evaluate the long-term effects of Metaverse- and VR-supported digital breastfeeding education on postnatal breastfeeding practices, self-efficacy, and motivation. It provides evidence on the sustained impact of technology-based educational models on breastfeeding behavior.
Study design
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
- Model description
- The study was designed as a prospective randomized controlled trial consisting of two parallel groups: an intervention group receiving Metaverse- and VR-supported education in the digital breastfeeding museum, and a control group receiving standard antenatal class education.
| Arm | Type | Receives |
|---|---|---|
| Routine Antenatal Class Education Program Group | No intervention | –In the previous randomized controlled study, no additional intervention was administered to the pregnant women in this group; they only received the routine breastfeeding education provided by the antenatal education program. In the prospective follow-up study, no additional postnatal education was provided; only long-term follow-up data were collected at four postpartum periods: 0-6 months, 6-12 months, 12-18 months, and 18-24 months. |
| Training Supported by Metaverse and VR in the Digital Breastfeeding Museum Group | Experimental | Other: Training Supported by Metaverse and Virtual Reality (VR) in the Digital Breastfeeding Museum Group, Device: Virtual Reality Headset (Meta Quest 2)In the previous randomized controlled study, pregnant women in this group received Metaverse- and virtual reality (VR)-supported education in a digital breastfeeding museum. The sole intervention consisted of a digital breastfeeding education program delivered via virtual reality and Metaverse platforms. All content was provided exclusively through head-mounted VR devices, without the need for any pharmacological agents or invasive procedures. The environment was explored by participants using virtual reality (VR) headsets (Meta Quest 2). In the prospective follow-up study, no additional postnatal education was provided; only long-term follow-up data were collected at four postpartum periods: 0-6 months, 6-12 months, 12-18 months, and 18-24 months. |
Who may qualify
- Ages
- 18 years and older
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (6 listed)
- Having previously participated in a randomized controlled trial by providing written informed consent,
- Primiparous mothers who voluntarily agree to participate in the new study,
- Being reachable by telephone and having digital access to complete an online questionnaire,
- Being able to read and understand Turkish,
- Having sufficient cognitive ability to recall the breastfeeding process,
Key exclusion criteria (3 listed)
- The presence of a serious health condition in the mother or infant that may contraindicate breastfeeding,
- Having experienced infant loss during the postpartum period,
- A diagnosis of a severe psychiatric or physiological condition in the mother during the postpartum period that may interfere with breastfeeding.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Training Supported by Metaverse and Virtual Reality (VR) in the Digital Breastfeeding Museum GroupIn the previous randomized controlled study, pregnant women in this group received Metaverse- and virtual reality (VR)-supported education in a digital breastfeeding museum. The sole intervention consisted of a digital breastfeeding education program delivered via virtual reality and Metaverse platforms. All content was provided exclusively through head-mounted VR devices, without the need for any pharmacological agents or invasive procedures. The environment was explored by participants using virtual reality (VR) headsets (Meta Quest 2). In the prospective follow-up study, no additional postnatal education was provided; only long-term follow-up data were collected at four postpartum periods: 0-6 months, 6-12 months, 12-18 months, and 18-24 months. | Other | Training Supported by Metaverse and VR in the Digital Breastfeeding Museum Group |
| Virtual Reality Headset (Meta Quest 2)A head-mounted virtual reality (VR) device used to deliver immersive educational content in a digital breastfeeding museum. Participants interacted with the virtual environment using VR headsets. | Device | Training Supported by Metaverse and VR in the Digital Breastfeeding Museum Group |
Primary outcome
Breastfeeding Motivation Scale
Time frame: Assessed during ongoing breastfeeding up to 24 months postpartum.
The Breastfeeding Motivation Scale was developed by Kestler-Peleg and colleagues in 2015. It is a 24-item, five-point Likert-type scale with five subscales. Cronbach's alpha coefficients for the subscales range from 0.56 to 0.89. The validity and reliability of the scale for the Turkish population were tested by Mızrak in 2017 among primiparous and multiparous women.The Turkish version of the Breastfeeding Motivation Scale for primiparous women consists of 23 items, five subscales, and uses a four-point Likert format. The subscales are: (1) integrated regulation, (2) intrinsic motivation - identified regulation, (3) introjected regulation - social approval, (4) introjected regulation - social pressure, and (5) external regulation - instrumental needs. The scale does not have a total score; subscale scores are evaluated individually. A higher score on a subscale indicates greater motivation in the domain represented by that subscale.
Breastfeeding Self-Efficacy Scale - Short Form (BSES-SF) Score
Time frame: 0-6 months, 6-12 months, 12-18 months, and 18-24 months postpartum
The Breastfeeding Self-Efficacy Scale is used to assess how confident mothers feel about their ability to breastfeed. The original scale was developed in 1999. In 2003, the scale was shortened to a 14-item version known as the Breastfeeding Self-Efficacy Scale - Short Form (BSES-SF), which is recommended for use in research and practice. The BSES-SF is a 5-point Likert-type scale, with responses ranging from 1 ("Not at all confident") to 5 ("Always confident"). The minimum possible score is 14, and the maximum is 70. Higher scores indicate higher levels of breastfeeding self-efficacy. The Turkish validity and reliability study of the scale was conducted in 2010. In this study, the Cronbach's alpha coefficient was reported as 0.86.
Breastfeeding Problems Assessment Scale
Time frame: 0-6 months, 6-12 months, 12-18 months, and 18-24 months postpartum
The Breastfeeding Problems Assessment Scale was developed by Karen Wambach in 1990. The validity and reliability of the Turkish version were established by Uyanık in 2019, with a Cronbach's alpha of 0.776. Turkish form consists only of the first section, containing 18 items across five subscales: mechanical concerns, process concerns, insufficient milk concerns, nipple concerns, and social concerns. Items are scored as follows: 1 = none, 2 = mild, 3 = moderate, 4 = severe, 5 = unbearable. Total scores range from 18 to 90, with higher scores indicating more severe breastfeeding problems. The scale has been reported as a valid tool for the Turkish population. In the present study, Cronbach's alpha was found to be 0.83.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 7 Apr 2026.
- Individual participant dataSharing planned: No. De-identified individual participant data (IPD) may be shared upon reasonable request.
Related trials for Metaverse
Not yet recruiting
Metaverse-based Versus Physical Infection Control Room of Errors in Nursing Students.
Metaverse, Student Satisfaction
Recruiting
Developing Resilience in Transgender and Nonbinary Individuals - Exploring the Impact of Social Challenges in the Metaverse
Resilience,Psychological, Well-Being, Psychological
Recruiting
The Effect of Gamified Metaverse-Based Training on Nursing Students' Self-Efficacy and Metaverse Perception Regarding Pressure Injury Management
Pressure Ulcers, Bedsores, Decubitus Ulcer, Nursing Education
Recruiting
The Effectiveness of Gamified Metaverse-Based Training on Patient Safety for Nursing Students
Gamification, Nursing Education
Active, not recruiting
Metaverse Applications in Clinical Neurorehabiliation: Device Feasibility
Neurological Disorder, Multiple Sclerosis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Assistant Professor Ayşenur AKKAYA GÜL, PhD principal investigator
Fenerbahce University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Training Supported by Metaverse and Virtual Reality (VR) in the Digital Breastfeeding Museum Group and Virtual Reality Headset (Meta Quest 2) in people with Metaverse and Virtual Reality, run by Uludag University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 7 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Breastfeeding Motivation Scale (time frame: Assessed during ongoing breastfeeding up to 24 months postpartum.). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Apr 2026.